26 Apr 2012

UCB Interim Report – first three months 2012

Read More
25 Apr 2012

First assessment of individual RLS domains in new post-hoc analyses of Neupro® studies

Read More
20 Apr 2012

New Neupro® data in Parkinson’s disease and Restless Legs Syndrome to be presented at the 64th American Academy of Neurology Annual Meeting

Read More
18 Apr 2012

UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology

Read More
16 Apr 2012

Cimzia® (certolizumab pegol) shows positive top-line phase 3 results in axial spondyloarthritis and ankylosing spondylitis

Read More
12 Apr 2012

Journalists recognised for excellence in reporting on epilepsy

Read More
11 Apr 2012

Transparency notification of Vanguard Health Care Fund

Read More
11 Apr 2012

UCB marks World Parkinson’s Disease Day with new ‘Parkinson’s Well-Being Map™’

Read More
5 Apr 2012

Transparency notification of Pharmahold SA – Cosylva SA – Compar Finance SA

Read More
5 Apr 2012

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
Subscribe to